Abivax Jumps 9.87%: Could This Signal a Fresh Uptrend?

Abivax (ABVX) Rockets Nearly 10% in Intraday Trading

• Abivax (ABVX) surged 9.87% during the trading session, reaching $111.515 by 17:17:49 on March 31, 2026.
• The stock experienced a sharp turnaround, with an intraday high of $112.0 and a low of $102.39.
• Options activity spiked, especially in April 10 call options at the $105 strike, where 140 contracts changed hands and turnover hit 105,064.

Abivax’s dramatic price jump has drawn significant market attention, as the stock approaches its 52-week high of $148.83. This move appears to be influenced by sector-wide momentum and active trading in the options market. Despite the Relative Strength Index (RSI) sitting at 35.16 and the MACD reflecting negative momentum, investors are debating whether this is the start of a sustained rally or simply a short-lived reversal.

ABVX Trend Snapshot

• Current Price: $111.970
• Change: +$10.470 (+10.32%)
• Exchange: NASDAQ
• Stock Type: Trading

Options Activity and Technical Breakout Drive ABVX Higher

Abivax’s sharp intraday rally is being fueled by a combination of technical signals and heightened options trading. The stock broke above its upper Bollinger Band at $127.81, signaling a possible reversal from its previous trading range. The most heavily traded options were April 10 calls, particularly the $105 strike, which saw a price change ratio of 191.10% and a turnover of 105,064 shares. Elevated implied volatility at 48.34% and a delta of 0.8047 reflect a bullish outlook among options traders. This surge seems to be driven by expectations of a positive catalyst or short-term momentum, as there is no major company news at this time.

Pharmaceutical Sector Update: ABVX Outpaces Peers

While Abivax posted a remarkable gain, the broader pharmaceutical sector remained relatively stable. Pfizer (PFE) led the sector with a modest 0.61% increase. Recent industry news, such as Gilead’s $7.8 billion acquisition of Arcellx and the FDA’s approval of an all-oral CLL treatment, have not sparked a sector-wide rally. This suggests Abivax’s move is more of a unique event rather than part of a broader trend, possibly signaling a speculative trade or a breakout after a period of consolidation.

Key Technical Indicators and Options to Watch

• MACD: -3.408 (below signal line), Signal Line: -1.653, Histogram: -1.755 (bearish divergence)
• RSI: 35.16 (indicating oversold conditions)
• Bollinger Bands: Price at $111.515, above upper band at $127.81, showing strong momentum
• 30-Day Moving Average: $117.92 (current price below this level)
• 200-Day Moving Average: $90.47 (serving as major support)

With the RSI in oversold territory and the MACD histogram showing contracting bearishness, Abivax may be poised for either a short-term reversal or continued upward momentum. The stock’s position above its 30-day moving average and near the upper Bollinger Band supports the case for further gains. Options trading activity also points to expectations of additional upside in the near term.

Highlighted Options Strategies

Top Option Pick 1: ABVX20260410C105 (Call Option)

• Contract Code: ABVX20260410C105
• Type: Call
• Strike Price: $105.00
• Expiration: April 10, 2026
• Implied Volatility: 48.34% (high, favorable for premium growth)
• Leverage Ratio: 13.21% (high leverage)
• Delta: 0.8047 (strong price sensitivity)
• Theta: -0.44196 (significant time decay, best for short-term trades)
• Gamma: 0.02928 (moderate sensitivity to price changes)
• Turnover: 105,064 (high liquidity)

This call option offers high leverage and benefits from the current price rally and increased volatility. With a delta near 1 and substantial turnover, it’s well-suited for traders seeking to profit from a continued rally before expiration. A 5% price increase from $111.515 to $117.09 could yield a $12.09 per share gain, or $12,090 per contract.

Top Option Pick 2: ABVX20260410C109 (Call Option)

• Contract Code: ABVX20260410C109
• Type: Call
• Strike Price: $109.00
• Expiration: April 10, 2026
• Implied Volatility: 39.90% (moderate, stable premium)
• Leverage Ratio: 22.11% (high leverage)
• Delta: 0.6859 (moderate price sensitivity)
• Theta: -0.40996 (high time decay, best for short-term moves)
• Gamma: 0.04561 (high sensitivity to price changes)
• Turnover: 1,122 (moderate liquidity)

This mid-strike call combines moderate delta with high gamma, making it attractive for traders expecting continued bullish momentum. A 5% rise to $117.09 would generate $8.09 per share, or $8,090 per contract. The balance of leverage and liquidity makes it suitable for both aggressive and moderate bullish strategies.

Traders with a bullish outlook may consider ABVX20260410C105 if the stock rebounds above $113.

Reviewing Abivax’s Performance After Major Intraday Gains

Historical analysis of ABVX following 10% intraday surges since 2022 shows a remarkable strategy return of 419.72%, far outpacing the benchmark’s 50.88%. This approach delivered an excess return of 368.84% and an impressive compound annual growth rate (CAGR) of 98.00%. However, this performance came with significant volatility, including a maximum drawdown of 68.82% and a Sharpe ratio of 0.81, highlighting the risks involved.

Backtest Summary

• Tested Asset: ABVX
• Entry Condition: Intraday price increase exceeding 10%
• Test Period: January 1, 2022 – March 31, 2026
• Strategy Return: +419.72%
• SPY Return: +50.88%
• Excess Return: +368.84%
• CAGR: +98.00%

Sample Trade Example

• Operation: Open
• Direction: Long
• Ticker: ABVX
• Entry Price: $109.220
• Date: March 26, 2026

Seize the Opportunity: ABVX’s Short-Term Bullish Setup

Abivax’s nearly 10% intraday rally is a standout event, driven by technical strength, robust options activity, and a decisive move above resistance. The technical landscape supports further gains, with RSI still in oversold territory and the stock trading above its 30-day average. Elevated turnover and implied volatility in April 10 options indicate the market is anticipating more upside in the near term. While the broader sector remains subdued, with Pfizer up just 0.61%, traders should keep a close eye on the $113 level. A breakout above this point could confirm the continuation of the bullish trend. For those looking to leverage this momentum, aggressive call options like ABVX20260410C105 provide high exposure to both price movement and volatility.